Dear Doctor Letter (Rote-Hand-Brief) on UVADEX™: Visual inspection of vials prior to administration
2011.12.29
Active substance:
Therakos Europe advises healthcare professionals to visually inspect the UVADEX™ vials prior to administration in order to exclude particle contamination. Furthermore, suspected cases of sepsis should be reported along with the numbers of the suspected batch(es).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN